BUSINESS● LOW3h ago · Sep 10, 2026, 4:35 PM
Biopharmaceutical Leader Kiniksa Poised To Hit New Buy Point After Big Revenue Beat
Yahoo Finance · global
Biopharmaceutical company Kiniksa is expected to reach a new buy point following a strong revenue performance. This indicates positive financial momentum for the company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESS21m agoAlexander Cadena leaves the presidency of CenitLa Silla VacíaBUSINESS27m agoTC Energy, DT Midstream raised at Morgan Stanley after weakness in gas pipeline stocksSeeking Alpha TechBUSINESS29m agoAvantis U.S. Small Cap Value ETF declares quarterly distribution of $0.4142Seeking Alpha TechBUSINESS29m agoAvantis U.S. Small Cap Equity ETF declares quarterly distribution of $0.2080Seeking Alpha Tech